Figure 1

![Figure 1: Analysis of the correlation between homocysteine levels, MTHFR genetic polymorphisms, and cognitive impairment severity in Parkinson's disease patients, suggesting hyperhomocysteinemia as an independent risk factor for cognitive decline.]()

> Source: María Teresa Periñán et al. "Homocysteine levels, genetic background, and cognitive impairment in Parkinson's." *Journal of neurology*, 2023. PMID: [36169739](https://pubmed.ncbi.nlm.nih.gov/36169739/)

<figure>
  <img src="" alt="Analysis of the correlation between homocysteine levels, MTHFR genetic polymorphisms, and cognitive impairment severity in Parkinson's disease patients, suggesting hyperhomocysteinemia as an independent risk factor for cognitive decline." />
  <figcaption>Figure 1. Analysis of the correlation between homocysteine levels, MTHFR genetic polymorphisms, and cognitive impairment severity in Parkinson's disease patients, suggesting hyperhomocysteinemia as an independent risk factor for cognitive decline.<br>  Source: María Teresa Periñán et al. "Homocysteine levels, genetic background, and cognitive impairment in Parkinson's." <em>Journal of neurology</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36169739/">36169739</a></figcaption>
</figure>